- Home
- Publications
- Publication Search
- Publication Details
Title
Drug-drug interactions of non-vitamin K oral anticoagulants
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 12, Issue 12, Pages 1445-1461
Publisher
Informa UK Limited
Online
2016-08-18
DOI
10.1080/17425255.2016.1225037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
- (2016) Blisse Vakkalagadda et al. American Journal of Cardiovascular Drugs
- Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin
- (2016) Barbara S. Wiggins et al. PHARMACOTHERAPY
- Bleeding events with dabigatran or warfarin in patients with venous thromboembolism
- (2016) Samuel Z. Goldhaber et al. THROMBOSIS AND HAEMOSTASIS
- Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation
- (2016) John Eikelboom et al. THROMBOSIS AND HAEMOSTASIS
- Relation Between Dabigatran Concentration, as Assessed Using the Direct Thrombin Inhibitor Assay, and Activated Clotting Time/Activated Partial Thromboplastin Time in Patients With Atrial Fibrillation
- (2015) Kenji Okubo et al. AMERICAN JOURNAL OF CARDIOLOGY
- Mechanism of Drug–Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer
- (2015) Ilia G. Denisov et al. BIOCHEMISTRY
- Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
- (2015) Charles E. Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Effect of Rifampin on the Pharmacokinetics of Edoxaban in Healthy Adults
- (2015) Jeanne Mendell et al. CLINICAL DRUG INVESTIGATION
- Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
- (2015) Hein Heidbuchel et al. EUROPACE
- In vitro and in vivo evaluation of drug-drug interaction between dabigatran and proton pump inhibitors
- (2015) Edouard Ollier et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- An open-label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics
- (2015) Jeanne Mendell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach
- (2015) Alexander Cohen et al. THROMBOSIS AND HAEMOSTASIS
- Drug Interactions Between Antiplatelet or Novel Oral Anticoagulant Medications and Antiretroviral Medications
- (2014) Gregory Egan et al. ANNALS OF PHARMACOTHERAPY
- Pharmacodynamics and pharmacokinetics during the transition from warfarin to rivaroxaban: a randomized study in healthy subjects
- (2014) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban
- (2014) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor
- (2014) Henri Bounameaux et al. DRUGS
- 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
- (2014) EUROPEAN HEART JOURNAL
- Laboratory Monitoring of the Non–Vitamin K Oral Anticoagulants∗
- (2014) Andrew D. Blann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
- (2014) Adam Cuker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gaps in translation from trials to practice: Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation
- (2014) Darae Ko et al. THROMBOSIS AND HAEMOSTASIS
- Comparison of the Efficacy and Safety of Two Rivaroxaban Doses in Acute Coronary Syndrome (from ATLAS ACS 2–TIMI 51)
- (2013) Jessica L. Mega et al. AMERICAN JOURNAL OF CARDIOLOGY
- Coadministration of Dabigatran Etexilate and Atorvastatin
- (2013) Joachim Stangier et al. American Journal of Cardiovascular Drugs
- Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
- (2013) Jeanne Mendell et al. American Journal of Cardiovascular Drugs
- Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2013) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
- (2013) Wolfgang Mueck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Gap between Trial Data and Clinical Practice - An Analysis of Case Reports on Bleeding Complications Occurring under Dabigatran and Rivaroxaban Anticoagulation
- (2013) Waltraud Pfeilschifter et al. CEREBROVASCULAR DISEASES
- Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment
- (2013) Jochen Graff et al. CLINICAL PHARMACOKINETICS
- Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2013) J. H. Alexander et al. EUROPEAN HEART JOURNAL
- New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
- (2013) J. Oldgren et al. EUROPEAN HEART JOURNAL
- The effect of food on the absorption and pharmacokinetics of rivaroxaban
- (2013) Jan Stampfuss et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- The Effects of the Antiplatelet Agents, Aspirin and Naproxen, on Pharmacokinetics and Pharmacodynamics of the Anticoagulant Edoxaban, a Direct Factor Xa Inhibitor
- (2013) Jeanne Mendell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Absence of Clinically Relevant Interactions between Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - and Digoxin or Atorvastatin in Healthy Subjects
- (2013) D Kubitza et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The P-Glycoprotein Transport System and Cardiovascular Drugs
- (2013) Jeffrey D. Wessler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention
- (2013) Morten Lamberts et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study - methodological implications for clinical trials
- (2013) G. Raskob et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- General mechanisms of coagulation and targets of anticoagulants (Section I)
- (2013) Steen Husted et al. THROMBOSIS AND HAEMOSTASIS
- Comparison of the CHADS2, CHA2DS2 -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial
- (2013) Stavros Apostolakis et al. THROMBOSIS AND HAEMOSTASIS
- Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin
- (2012) Sebastian Härtter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
- (2012) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects
- (2012) Sebastian Härtter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A semi-mechanistic absorption model to evaluate drug-drug interaction with dabigatran: application with clarithromycin
- (2012) Xavier Delavenne et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Oral Anticoagulant Therapy
- (2012) Walter Ageno et al. CHEST
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
- (2012) Antonio L. Dans et al. CIRCULATION
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2012) et al. EUROPEAN HEART JOURNAL
- Pharmacokinetics of the Direct Factor Xa Inhibitor Edoxaban and Digoxin Administered Alone and in Combination
- (2012) Jeanne Mendell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients
- (2012) Stavros Apostolakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: No increased risk of bleeding
- (2012) Andreas Kurth et al. THROMBOSIS AND HAEMOSTASIS
- A randomised assessment of the pharmacokinetic, pharmacodynamic and safety interaction between apixaban and enoxaparin in healthy subjects
- (2012) Jessie Wang et al. THROMBOSIS AND HAEMOSTASIS
- Edoxaban administration following enoxaparin: A pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects
- (2012) Nobuko Matsushima et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature
- (2012) Jonathan Douxfils et al. THROMBOSIS RESEARCH
- The Use of Dabigatran in Elderly Patients
- (2011) Matthieu Legrand ARCHIVES OF INTERNAL MEDICINE
- Guidelines on oral anticoagulation with warfarin - fourth edition
- (2011) David Keeling et al. BRITISH JOURNAL OF HAEMATOLOGY
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor
- (2011) Kan He et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin
- (2011) Joachim Stangier et al. JOURNAL OF CLINICAL PHARMACOLOGY
- In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
- (2011) M. J. Gnoth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
- (2011) K.-H. LIESENFELD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Incidence and Severity of Coronary Artery Disease in Patients with Atrial Fibrillation Undergoing First-Time Coronary Angiography
- (2011) Stefan Kralev et al. PLoS One
- Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilate
- (2011) Norio Yamamura et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Rivaroxaban: A New Oral Factor Xa Inhibitor
- (2010) Elisabeth Perzborn et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2010) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Randomized Study of the Effects of Food on the Pharmacokinetics of Once-Daily Extended-Release Hydromorphone in Healthy Volunteers
- (2010) Kenneth Todd Moore et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Verapamil sustained release: New formulation and convolution
- (2010) Chien Nguyen et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
- (2009) CIRCULATION
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects
- (2009) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans
- (2009) C. Weinz et al. DRUG METABOLISM AND DISPOSITION
- In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
- (2009) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
- (2009) JL Mega et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban – an oral, direct factor Xa inhibitor – in elderly Chinese subjects
- (2009) J. Jiang et al. THROMBOSIS AND HAEMOSTASIS
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
- (2008) Dagmar Kubitza et al. CURRENT MEDICAL RESEARCH AND OPINION
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
- Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment
- (2008) Joachim Stangier et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
- (2008) S.-F. Zhou XENOBIOTICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now